Management of menopause: a view towards prevention

Area of Science:

• Reproductive Endocrinology
• Gerontology
• Preventative Medicine

Background:

• Menopause, occurring around age 50, impacts women for about one-third of their lives.
• Significant metabolic and cardiovascular disease risks emerge during the menopausal transition.
• Conditions like obesity, diabetes, osteoporosis, and cardiovascular disease often manifest 10-15 years post-menopause.

Purpose of the Study:

• To highlight menopause as a key opportunity for instituting preventative health strategies.
• To discuss strategies for managing menopausal symptoms and asymptomatic conditions.
• To evaluate the role of hormone therapy in mitigating menopausal health risks.

Main Methods:

• Review of current medical literature on menopause and associated health risks.
• Analysis of preventative strategies, including hormone therapy.
• Examination of data on the timing and duration of hormone therapy for optimal benefit.

Main Results:

• Menopause presents a crucial window for preventative interventions to improve quality of life and reduce mortality.
• Hormone therapy is effective for menopausal symptoms and osteoporosis, and can enhance metabolic and cardiovascular health.
• Early initiation of estrogen therapy (under 60) in low-risk women shows a consistent decrease in mortality with a favorable risk-benefit profile; long-term therapy may not be necessary.

Conclusions:

• Proactive health strategies during menopause are essential for long-term well-being.
• Hormone therapy, particularly when started early, offers significant benefits for postmenopausal women.
• Personalized preventative care can mitigate the risks associated with menopause and aging.